Literature DB >> 20498630

Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability.

S Lecomte1, F Desmots, F Le Masson, P Le Goff, D Michel, E S Christians, Y Le Dréan.   

Abstract

A single heat shock factor (HSF), mediating the heat shock response, exists from yeast to Drosophila, whereas several related HSFs have been found in mammals. This raises the question of the specific or redundant functions of the different members of the HSF family and in particular of HSF1 and HSF2, which are both ubiquitously expressed. Using immortalized mouse embryonic fibroblasts (iMEFs) derived from wild-type, Hsf1(-/-), Hsf2(-/-) or double-mutant mice, we observed the distinctive behaviors of these mutants with respect to proteasome inhibition. This proteotoxic stress reduces to the same extent the viability of Hsf1(-/-)- and Hsf2(-/-)-deficient cells, but through different underlying mechanisms. Contrary to Hsf2(-/-) cells, Hsf1(-/-) cells are unable to induce pro-survival heat shock protein expression. Conversely, proteasome activity is lower in Hsf2(-/-) cells and the expression of some proteasome subunits, such as Psmb5 and gankyrin, is decreased. As gankyrin is an oncoprotein involved in p53 degradation, we analyzed the status of p53 in HSF-deficient iMEFs and observed that it was strongly stabilized in Hsf2(-/-) cells. This study points a new role for HSF2 in the regulation of protein degradation and suggests that pan-HSF inhibitors could be valuable tools to reduce chemoresistance to proteasome inhibition observed in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498630     DOI: 10.1038/onc.2010.171

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Mammalian Heat Shock Response and Mechanisms Underlying Its Genome-wide Transcriptional Regulation.

Authors:  Dig B Mahat; H Hans Salamanca; Fabiana M Duarte; Charles G Danko; John T Lis
Journal:  Mol Cell       Date:  2016-03-24       Impact factor: 17.970

2.  High-throughput screening system for inhibitors of human Heat Shock Factor 2.

Authors:  Levi M Smith; Dwipayan Bhattacharya; Daniel J Williams; Ivan Dixon; Nicholas R Powell; Tamara Y Erkina; Alexandre M Erkine
Journal:  Cell Stress Chaperones       Date:  2015-05-24       Impact factor: 3.667

Review 3.  Tailoring of Proteostasis Networks with Heat Shock Factors.

Authors:  Jenny Joutsen; Lea Sistonen
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

4.  HSFs and regulation of Hsp70.1 (Hspa1b) in oocytes and preimplantation embryos: new insights brought by transgenic and knockout mouse models.

Authors:  Florent Le Masson; Elisabeth Christians
Journal:  Cell Stress Chaperones       Date:  2010-10-30       Impact factor: 3.667

Review 5.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

6.  The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.

Authors:  Antonio Rossi; Anna Riccio; Marta Coccia; Edoardo Trotta; Simone La Frazia; M Gabriella Santoro
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

Review 7.  Roles of heat shock factor 1 beyond the heat shock response.

Authors:  János Barna; Péter Csermely; Tibor Vellai
Journal:  Cell Mol Life Sci       Date:  2018-05-17       Impact factor: 9.261

8.  Unraveling complex interplay between heat shock factor 1 and 2 splicing isoforms.

Authors:  Sylvain Lecomte; Léa Reverdy; Catherine Le Quément; Florent Le Masson; Axelle Amon; Pascale Le Goff; Denis Michel; Elisabeth Christians; Yves Le Dréan
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Heat shock factor 2 is required for maintaining proteostasis against febrile-range thermal stress and polyglutamine aggregation.

Authors:  Toyohide Shinkawa; Ke Tan; Mitsuaki Fujimoto; Naoki Hayashida; Kaoru Yamamoto; Eiichi Takaki; Ryosuke Takii; Ramachandran Prakasam; Sachiye Inouye; Valerie Mezger; Akira Nakai
Journal:  Mol Biol Cell       Date:  2011-08-03       Impact factor: 4.138

10.  Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples.

Authors:  Michael F Gallagher; Cynthia Cbb Heffron; Alexandros Laios; Sharon A O'Toole; Brendan Ffrench; Paul C Smyth; Richard J Flavin; Salah A Elbaruni; Cathy D Spillane; Cara M Martin; Orla M Sheils; John J O'Leary
Journal:  J Ovarian Res       Date:  2012-01-19       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.